Milestone - Clonex Sdn Bhd

Milestone

Home » Milestone

Transforming Cancer Detection with GlycoCapture® Technology

Knowing when and where to use 3D printing provides users the flexibility needed at the right time. With CLONEX, you can do just that even for researchers and lab users.The global liquid biopsy for early cancer detection and monitoring market size was estimated at USD 2.23 billion in 2024 and is projected to reach USD 6.20 billion by 2033, growing at a CAGR of 12.14% from 2025 to 2033. Exosome/EV’s are poised within the same high-growth markets.

First in Malaysia: Biocomputational Simulation, Modelling and Analysis Service for Molecular Biology & Chemistry.

We at CLONEX, successfully completed a project with our customers who required simulation and computational analysis on proprietary molecules without any existing structural models or prior simulation examples for their research/patented discoveries.

3D Printing as an Adaptive Solution for Daily Lab Use

Knowing when and where to use 3D printing provides users the flexibility needed at the right time. With CLONEX, you can do just that even for researchers and lab users. Our customer using ROCKER-brand Lafill 100 portable aspirator model, required adapter that would be able to hold in serological pipettes similar to a pipette gun unto the Lafill 100’s powerful suction handle.

Ready to Innovate and need our assistance?

Empowering research and development through innovative biotechnology solutions designed for industry and progress.

Quick Link

Get In Touch

Subscribe Our Newsletter

Follow Us

Services

Copyright 2025. All rights reserved by CLONEX (M) SDN. BHD. SSM: 202301051929 (1545843-W).